StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical operating margin

Operating margin is operating income as a percentage of revenue.

Rockwell Medical's operating margin for the twelve months ending Jun 30, 2026 was -6.5%. For fiscal 2025 it was -6.8%, against 0.6% the year before. The highest annual figure on record is 0.6% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-6.8%−7.4
FY2024Dec 31, 20240.6%+8.6
FY2023Dec 31, 2023-8.0%+15.1
FY2022Dec 31, 2022-23.0%+25.9
FY2021Dec 31, 2021-49.0%−3.3
FY2020Dec 31, 2020-45.7%+10.6
FY2019Dec 31, 2019-56.3%−5.1
FY2018Dec 31, 2018-51.2%−5.9
FY2017Dec 31, 2017-45.2%−7.3
FY2016Dec 31, 2016-37.9%−10.6
FY2015Dec 31, 2015-27.3%+5.1
FY2014Dec 31, 2014-32.4%+57.4
FY2013Dec 31, 2013-89.8%+19.0
FY2012Dec 31, 2012-108.9%−64.6
FY2011Dec 31, 2011-44.3%−39.5
FY2010Dec 31, 2010-4.8%+5.2
FY2009Dec 31, 2009-10.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-6.0%+2.4
Q1 FY2026Mar 31, 2026-8.5%−1.3
Q4 FY2025Dec 31, 2025-2.2%−0.1
Q3 FY2025Sep 30, 2025-9.9%−16.8
Q2 FY2025Jun 30, 2025-8.4%−10.4
Q1 FY2025Mar 31, 2025-7.2%−1.4
Q4 FY2024Dec 31, 2024-2.1%+0.4
Q3 FY2024Sep 30, 20246.8%+14.1
Q2 FY2024Jun 30, 20242.0%+18.4
Q1 FY2024Mar 31, 2024-5.8%+1.4
Q4 FY2023Dec 31, 2023-2.5%+7.7
Q3 FY2023Sep 30, 2023-7.3%+12.5
Q2 FY2023Jun 30, 2023-16.4%+7.6
Q1 FY2023Mar 31, 2023-7.3%+33.8
Q4 FY2022Dec 31, 2022-10.2%+44.3
Q3 FY2022Sep 30, 2022-19.8%+23.8
Q2 FY2022Jun 30, 2022-24.0%+27.7
Q1 FY2022Mar 31, 2022-41.1%+5.3
Q4 FY2021Dec 31, 2021-54.5%−1.3
Q3 FY2021Sep 30, 2021-43.6%+0.2
Q2 FY2021Jun 30, 2021-51.7%−16.4
Q1 FY2021Mar 31, 2021-46.4%+4.4
Q4 FY2020Dec 31, 2020-53.2%−5.4
Q3 FY2020Sep 30, 2020-43.8%+7.8
Q2 FY2020Jun 30, 2020-35.2%+34.6
Q1 FY2020Mar 31, 2020-50.8%+5.8
Q4 FY2019Dec 31, 2019-47.8%+8.1
Q3 FY2019Sep 30, 2019-51.5%−21.6
Q2 FY2019Jun 30, 2019-69.9%+12.6
Q1 FY2019Mar 31, 2019-56.6%−18.4
Q4 FY2018Dec 31, 2018-55.9%+6.2
Q3 FY2018Sep 30, 2018-30.0%+4.4
Q2 FY2018Jun 30, 2018-82.5%−31.7
Q1 FY2018Mar 31, 2018-38.3%−4.3
Q4 FY2017Dec 31, 2017-62.1%−22.8
Q3 FY2017Sep 30, 2017-34.4%+2.7
Q2 FY2017Jun 30, 2017-50.7%–
Q1 FY2017Mar 31, 2017-34.0%–
Q4 FY2016Dec 31, 2016-39.3%–
Q3 FY2016Sep 30, 2016-37.1%–

More Rockwell Medical figures

See a number that looks wrong?